Morgan Stanley Cuts Price Target on IRhythm Technologies to $130 From $135, Keeps Overweight Rating
ProFrac Holding Analyst Ratings
Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating
Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating
JPMorgan Downgrades Altair Engineering to Neutral From Overweight, Price Target Is $95
Core Laboratories (CLB) Gets a Hold From Piper Sandler
Piper Sandler Remains a Buy on Solaris Oilfield Infrastructure (SOI)
Oil States International (OIS) Gets a Hold From Piper Sandler
Propetro Holding (PUMP) Receives a Buy From Piper Sandler
Piper Sandler Reaffirms Their Hold Rating on Chart Industries (GTLS)
Analysts Conflicted on These Technology Names: Squarespace (SQSP), Akamai (AKAM) and Exlservice Holdings (EXLS)
Benchmark Co. Sticks to Their Buy Rating for Omnicell (OMCL)
Piper Sandler Keeps Their Hold Rating on Helmerich & Payne (HP)
Piper Sandler Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)
Piper Sandler Remains a Buy on Fastly (FSLY)
ChampionX (CHX) Gets a Hold From Piper Sandler
Piper Sandler Remains a Hold on DigitalOcean Holdings (DOCN)
Piper Sandler Remains a Buy on ProFrac Holding (ACDC)
TransMedics Group (TMDX) Receives a Buy From Piper Sandler
Piper Sandler Reaffirms Their Buy Rating on Harmony Biosciences Holdings (HRMY)